Table 2

Susceptibility profile of uropathogens isolated from symptomatic outpatients at Gulu regional hospital, northern Uganda (n = 82)
Uro-isolates Staphylococcus spp. n = 38 E. coli n = 32 Klebsiella spp. n = 4 P. mirabilis n = 2 E. faecalis n = 6
Antibiotic disks S I R S I R S I R S I R S I R
Nitrofurantoin (50 μg) 8 14 16 10 5 17 0 1 3 0 0 2 4 0 2
Nalidixic acid (30 μg) 4 10 24 13 6 13 0 2 2 0 0 2 2 2 2
Cotrimoxazole (25/125 μg) 5 5 28 5 5 22 0 0 4 0 0 2 2 0 4
Amoxicillin (10 μg) 16 6 16 10 3 19 0 1 3 0 2 0 2 0 4
Amoxi/clav (20/10 μg) 26 3 9 10 10 12 0 4 0 0 2 0 3 1 2
Cephalexin (30 μg) 16 13 9 5 8 19 3 1 0 0 0 2 2 0 4
Ciprofloxacin (5 μg) 24 0 14 19 5 8 3 1 0 2 0 0 4 0 2
Levofloxacin (5 μg) 29 2 7 13 9 10 2 2 0 2 0 0 3 1 2
Gentamicin (10 μg) 24 7 7 26 1 5 4 0 0 2 0 0 6 0 0
Azithromycin (15 μg) 6 9 23 10 17 5 4 0 0 1 1 0 5 1 0
Oxacillin (10 μg)* 7 0 2 - - - - - - - - - - - -

Key: S, Sensitive; I, Intermediate; R, Resistant; * tested on Staphylococcus aureus only (n = 9).

Odongo et al.

Odongo et al. BMC Infectious Diseases 2013 13:193   doi:10.1186/1471-2334-13-193

Open Data